日本黄色小说视频,日韩在线一区二区三区免费视频,亚洲电影在线,精品欧美日韩一区二区三区,久久香蕉国产线看观看亚洲卡,美女浴室,美女脱衣诱惑

資訊|論壇|病例

搜索

首頁(yè) 醫(yī)學(xué)論壇 專(zhuān)業(yè)文章 醫(yī)學(xué)進(jìn)展 簽約作者 病例中心 快問(wèn)診所 愛(ài)醫(yī)培訓(xùn) 醫(yī)學(xué)考試 在線(xiàn)題庫(kù) 醫(yī)學(xué)會(huì)議

您所在的位置:首頁(yè) > 肝病科診療指南 > 2006NLA他汀肝臟安全性評(píng)估共識(shí)

2006NLA他汀肝臟安全性評(píng)估共識(shí)

2014-05-04 15:50 閱讀:2840 來(lái)源:愛(ài)愛(ài)醫(yī) 責(zé)任編輯:張子玲
[導(dǎo)讀] The Liver Expert Panel of the NationalLipid Association (NLA) affirms that there is a relationbetween statin therapy and elevations in serum aminotrans-ferase levels.

    《2006NLA他汀肝臟安全性評(píng)估共識(shí)》內(nèi)容簡(jiǎn)介:

    This has been consistently dem-onstrated in clinical trials performed during statin phase 2and 3 development programs and in long-term, end pointtrials.1The prescribing ***rmation for each statin citesthese associations. Aminotransferase elevations 3 timesthe upper limit of normal generally occur in 1% of pa-tients across the dose range for marketed statins; the excep-tions are aminotransferase elevations of this magnitude thatoccur in 2%–3% of patients receiving atorvastatin 80 mg/day or the combination of ezetimibe and a statin.

    《2006NLA他汀肝臟安全性評(píng)估共識(shí)》內(nèi)容預(yù)覽:

    Are statin-associated elevations in aminotransferase

    levels indicative of liver damage or dysfunction?

    ● Response: No

    ● Confidence/level of evidence: 2C

    RATIONALE. Isolated elevations of aminotransferases in theabsence of increased bilirubin levels have not been linkedclinically or histologically with evidence of acute or chronicliver injury.6 - 8Other mechanisms have been proposed thatcould explain commonly observed aminotransferase elevationsin individuals treated with statins, including a transient phar-macologic effect secondary to cholesterol reduction in hepato-cytes, comorbid conditions such as diabetes mellitus and obe-sity, and the consumption of alcohol or nonstatin medications.6Are statin-associated elevations in aminotransferasesa class effect?

    ● Response: Yes

    ● Confidence/level of evidence: 1A

    RATIONALE. The Liver Expert Panel affirms that eleva-tions in aminotransferase levels have been reported with alldoses of all marketed statins and that no particular statinappears to cause these elevations more frequently than oth-ers. This observation is supported by the official productlabeling for each marketed statin2,3,9 -13and by long-termrandomized end point trials.1A recent meta-**ysis of 13of these clinical trials, involving 49,275 patients, supportsthis assertion.14Whereas fluvastatin demonstrated statisti-cally significant higher aminotransferase elevations at cer-tain doses in this meta-**ysis, the Panel was not persuadedthat this difference is clinically significant.

    點(diǎn)擊下載***:《2006NLA他汀肝臟安全性評(píng)估共識(shí)》


分享到:
  版權(quán)聲明:

  本站所注明來(lái)源為"愛(ài)愛(ài)醫(yī)"的文章,版權(quán)歸作者與本站共同所有,非經(jīng)授權(quán)不得轉(zhuǎn)載。

  本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的,且明確注明來(lái)源和作者,不希望被轉(zhuǎn)載的媒體或個(gè)人可與我們

  聯(lián)系z(mì)lzs@120.net,我們將立即進(jìn)行刪除處理

意見(jiàn)反饋 關(guān)于我們 隱私保護(hù) 版權(quán)聲明 友情鏈接 聯(lián)系我們

Copyright 2002-2024 Iiyi.Com All Rights Reserved